Company / Current Liabilities per Share
Aquestive Therapeutics, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.52
FY2025
5-year range
$0.28 / $0.96
FY2021-FY2025
Trend
+89.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.52.
Based on SEC 10-K filings.
0.52 in FY2025 with a 5-year CAGR of -3.7%.
Increased from $0.33 to $0.52 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -18.4%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 89.2% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.52 | +89.2% |
| FY2024 | $0.28 | -17.6% |
| FY2023 | $0.33 | -65.2% |
| FY2022 | $0.96 | +50.9% |
| FY2021 | $0.64 | +1.0% |
| FY2020 | $0.63 | -15.4% |
| FY2019 | $0.74 | -43.7% |
| FY2018 | $1.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026